DK1135112T3 - Oral formulering til gastrointestinal lægemiddeladministration - Google Patents

Oral formulering til gastrointestinal lægemiddeladministration

Info

Publication number
DK1135112T3
DK1135112T3 DK99972918T DK99972918T DK1135112T3 DK 1135112 T3 DK1135112 T3 DK 1135112T3 DK 99972918 T DK99972918 T DK 99972918T DK 99972918 T DK99972918 T DK 99972918T DK 1135112 T3 DK1135112 T3 DK 1135112T3
Authority
DK
Denmark
Prior art keywords
layer
drug
oral formulation
protecting
drug administration
Prior art date
Application number
DK99972918T
Other languages
Danish (da)
English (en)
Inventor
Kanji Takada
Original Assignee
Kanji Takada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanji Takada filed Critical Kanji Takada
Application granted granted Critical
Publication of DK1135112T3 publication Critical patent/DK1135112T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99972918T 1998-11-27 1999-11-26 Oral formulering til gastrointestinal lægemiddeladministration DK1135112T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP35396698 1998-11-27
JP26643399 1999-09-21
EP99972918A EP1135112B1 (en) 1998-11-27 1999-11-26 An oral formulation for gastrointestinal drug delivery

Publications (1)

Publication Number Publication Date
DK1135112T3 true DK1135112T3 (da) 2005-02-14

Family

ID=26547440

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99972918T DK1135112T3 (da) 1998-11-27 1999-11-26 Oral formulering til gastrointestinal lægemiddeladministration

Country Status (17)

Country Link
US (1) US7097851B1 (es)
EP (1) EP1135112B1 (es)
JP (1) JP4497725B2 (es)
KR (1) KR100762475B1 (es)
CN (1) CN1161107C (es)
AT (1) ATE279914T1 (es)
AU (1) AU766293B2 (es)
BR (1) BR9916871A (es)
CA (1) CA2352389C (es)
DE (1) DE69921353T2 (es)
DK (1) DK1135112T3 (es)
ES (1) ES2233106T3 (es)
HK (1) HK1043545A1 (es)
ID (1) ID29085A (es)
IL (1) IL143356A0 (es)
MX (1) MXPA01005346A (es)
WO (1) WO2000032172A1 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1284137B1 (en) * 2000-05-26 2010-12-01 TAKADA, Kanji Nonoral preparation having three-layer structure
KR20040018333A (ko) * 2001-02-16 2004-03-03 시미즈 세이야꾸 가부시키가이샤 소장 전달용 점액다당류 함유 경구 제형, 및 순환 장애치료에서의 이들의 용도
DE10120092B4 (de) * 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
AU2002319653A1 (en) * 2001-07-20 2003-03-03 Samir Mitragotri Method for oral drug delivery
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
WO2003026699A1 (fr) * 2001-09-26 2003-04-03 Tanabe Seiyaku Co., Ltd. Compositions medicinales favorisant l'absorption de medicaments
US20060034929A1 (en) * 2001-12-27 2006-02-16 Brubaker Michael J Sustained release drug delivery devices with prefabricated permeable plugs
US7200424B2 (en) 2002-07-15 2007-04-03 Bellsouth Intelectual Property Corporation Systems and methods for restricting the use and movement of telephony devices
US8275371B2 (en) * 2002-07-15 2012-09-25 At&T Intellectual Property I, L.P. Apparatus and method for providing communications and connection-oriented services to devices
US8543098B2 (en) 2002-07-15 2013-09-24 At&T Intellectual Property I, L.P. Apparatus and method for securely providing communications between devices and networks
US8554187B2 (en) 2002-07-15 2013-10-08 At&T Intellectual Property I, L.P. Apparatus and method for routing communications between networks and devices
US8526466B2 (en) 2002-07-15 2013-09-03 At&T Intellectual Property I, L.P. Apparatus and method for prioritizing communications between devices
TWI355276B (en) 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
PT1682537E (pt) 2003-11-05 2012-06-20 Sarcode Bioscience Inc Moduladores de adesão celular
WO2006026556A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Bioadhesive rate-controlled oral dosage formulations
KR100638041B1 (ko) * 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
JP4606748B2 (ja) * 2004-02-06 2011-01-05 京セラケミカル株式会社 固形製剤の製造方法
AR048033A1 (es) * 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
AT502098B8 (de) * 2004-07-07 2007-06-15 Albert Dr Missbichler Diaminooxidase-hältige zusammensetzung
JP4787503B2 (ja) * 2005-01-12 2011-10-05 京セラケミカル株式会社 固形製剤の製造方法
JP4787507B2 (ja) * 2005-01-24 2011-10-05 京セラケミカル株式会社 固形製剤及びその製造方法
JP2008155067A (ja) * 2005-04-14 2008-07-10 Toray Eng Co Ltd マイクロカプセル製造方法、マイクロカプセル製造装置、およびマイクロカプセルシート
DK1881823T3 (en) 2005-05-17 2015-03-02 Sarcode Bioscience Inc COMPOSITION AND PROCEDURES FOR TREATMENT OF EYE DISORDERS
WO2007083698A1 (ja) * 2006-01-19 2007-07-26 Toray Engineering Co., Ltd, 積層型マイクロカプセルシートおよびその製造方法
JP2007246412A (ja) * 2006-03-14 2007-09-27 Serubakku:Kk 消化管用経口製剤とその製造方法および消化管用経口カプセル剤
US20100136123A1 (en) * 2006-10-12 2010-06-03 Toray Engineering Co., Ltd. Microcapsule Sheet
AU2008238634B2 (en) * 2007-03-30 2013-01-17 Lintec Corporation Film-like orally administered medication and manufacturing method therefor
US20100303901A1 (en) * 2007-04-26 2010-12-02 Eyal Shimoni Oral delivery of proteins and peptides
US20090105561A1 (en) * 2007-10-17 2009-04-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US8303573B2 (en) 2007-10-17 2012-11-06 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8789536B2 (en) 2007-10-17 2014-07-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8707964B2 (en) * 2007-10-31 2014-04-29 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
ES2830024T3 (es) 2007-10-19 2021-06-02 Novartis Ag Composiciones y métodos para el tratamiento del edema macular
US8808276B2 (en) * 2007-10-23 2014-08-19 The Invention Science Fund I, Llc Adaptive dispensation in a digestive tract
US8808271B2 (en) * 2007-10-31 2014-08-19 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8109920B2 (en) * 2007-10-31 2012-02-07 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US8333754B2 (en) * 2007-10-31 2012-12-18 The Invention Science Fund I, Llc Medical or veterinary digestive tract utilization systems and methods
US20090163894A1 (en) * 2007-10-31 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Medical or veterinary digestive tract utilization systems and methods
US20090137866A1 (en) * 2007-11-28 2009-05-28 Searete Llc, A Limited Liability Corporation Of The State Delaware Medical or veterinary digestive tract utilization systems and methods
US8080562B2 (en) * 2008-04-15 2011-12-20 Sarcode Bioscience Inc. Crystalline pharmaceutical and methods of preparation and use thereof
MX2020005326A (es) 2008-08-15 2022-03-03 Ironwood Pharmaceuticals Inc Formulaciones que contienen linaclotida para administracion oral.
MX2012001660A (es) 2009-08-06 2012-03-26 Ironwood Pharmaceuticals Inc Formulaciones que contienen linaclotida para adminstracion oral.
WO2011050175A1 (en) 2009-10-21 2011-04-28 Sarcode Corporation Crystalline pharmaceutical and methods of preparation and use thereof
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
JP2013514976A (ja) 2009-12-16 2013-05-02 ノッド ファーマシューティカルズ， インコーポレイテッド 経口薬物送達のための組成物および方法
WO2011103311A2 (en) 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc Treatments for gastrointestinal disorders
US20140005128A1 (en) 2010-08-11 2014-01-02 Forest Laboratories Holdings Limited Treatments of gastrointestinal disorders
US9782354B2 (en) * 2010-08-25 2017-10-10 II Grant Rufus Sparling Enteric active substance delivery
US9808418B2 (en) 2010-11-26 2017-11-07 University Of The Witwatersrand, Johannesburg Pharmaceutical dosage form
EP2776055B1 (en) 2011-08-17 2016-12-14 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
CN110922393A (zh) 2012-07-25 2020-03-27 诺华股份有限公司 Lfa-1抑制剂及其多晶型物
CN110809464A (zh) * 2017-06-27 2020-02-18 株式会社培旺精廉宅 粘膜附着性口服制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
JPS61280423A (ja) * 1985-06-05 1986-12-11 Kiyuukiyuu Yakuhin Kogyo Kk 口腔内粘膜貼付剤
JPH07121859B2 (ja) * 1986-03-18 1995-12-25 第一製薬株式会社 徐放性カプセル剤
US5196202A (en) * 1986-09-01 1993-03-23 Teikoku Seiyaku Kabushiki Kaisha Sustained release dosage form
US5236713A (en) * 1987-10-21 1993-08-17 Teikoku Seiyaku Kabushiki Kaisha Preparation for intermittently releasing active agent applicable to oral cavity
US5350741A (en) 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US5496559A (en) * 1991-04-08 1996-03-05 Sumitomo Pharmaceuticals Company, Limited Porous solid formulations containing proteinaceous physiologically active substances
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
AU7568394A (en) * 1993-08-19 1995-03-14 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
US5637319A (en) 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
US6231888B1 (en) * 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US6086869A (en) * 1996-11-22 2000-07-11 Toray Industries, Inc. Use of interferon-β or γ to treat retinal edema
WO1998024412A2 (en) * 1996-12-05 1998-06-11 The Board Of Trustees Of The University Of Illinois Compounds useful against diseases of the colon and methods for orally administering same
AU2546399A (en) * 1998-02-10 1999-08-30 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release

Also Published As

Publication number Publication date
MXPA01005346A (es) 2003-03-27
DE69921353D1 (de) 2004-11-25
WO2000032172A1 (en) 2000-06-08
KR100762475B1 (ko) 2007-10-04
CA2352389C (en) 2009-01-20
US7097851B1 (en) 2006-08-29
EP1135112B1 (en) 2004-10-20
ES2233106T3 (es) 2005-06-01
CN1333680A (zh) 2002-01-30
ATE279914T1 (de) 2004-11-15
DE69921353T2 (de) 2005-11-10
IL143356A0 (en) 2002-04-21
HK1043545A1 (zh) 2002-09-20
JP2002531394A (ja) 2002-09-24
AU766293B2 (en) 2003-10-16
ID29085A (id) 2001-07-26
KR20010086057A (ko) 2001-09-07
AU1410100A (en) 2000-06-19
CN1161107C (zh) 2004-08-11
CA2352389A1 (en) 2000-06-08
JP4497725B2 (ja) 2010-07-07
EP1135112A1 (en) 2001-09-26
BR9916871A (pt) 2001-08-21

Similar Documents

Publication Publication Date Title
DK1135112T3 (da) Oral formulering til gastrointestinal lægemiddeladministration
DK0938316T3 (da) Opioidantagonistholdig galenisk formulering
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
DK1079813T3 (da) Farmaceutisk bæreranordning, der er egnet til administration af farmaceutiske forbindelser til slimhindeoverflader
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
AU6776700A (en) Implantable drug delivery catheter system with capillary interface
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
NO20014035D0 (no) System for oral administrasjon av medikament
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
ATE444768T1 (de) Wirkstoffabgabesysteme
WO2005050526A8 (en) System for maintaining drug information and communicating with medication delivery devices
PT973497E (pt) Dispositivo transportador farmaceutico adequado para administracao de compostos farmaceuticos a superficies mucosas
ATE493115T1 (de) Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum
WO2001082897A3 (en) Liposome drug delivery
WO2001041742A3 (en) Antiviral medication
AU3520900A (en) Implantable drug delivery system
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
EP2474307A3 (en) Proliposomal drug delivery system
AU4955200A (en) A method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs
FR2796287B1 (fr) Dispositif d'administration de medicament
AU1751997A (en) Targeted delivery of drugs to the lower gastrointestinal tract
ATE296115T1 (de) Ortsspezifische arzneimittel verabreichung
AU6503399A (en) Drug delivery catheter
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten